Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$861,503,863
+$206,093,237 QoQ
Shares Held
718,261
+0.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#95
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. LLY ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
|
4,977,327 | $119,854,034 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $861,503,863 | 718,261 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $655,410,626 | 712,581 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $746,181,559 | 694,329 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $521,119,844 | 682,988 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $485,029,022 | 622,207 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $473,126,673 | 572,855 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $381,453,692 | 494,111 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $454,515,570 | 513,032 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $451,854,334 | 499,077 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $317,046,706 | 407,536 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $229,509,594 | 393,724 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $203,574,418 | 379,004 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $180,522,126 | 384,925 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $80,378,137 | 234,052 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $106,934,666 | 292,299 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $78,784,227 | 243,650 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,859,619 | 240,137 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $66,021,744 | 230,547 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $76,681,434 | 277,610 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $64,456,248 | 278,971 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $66,611,982 | 290,223 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $55,644,149 | 297,849 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $47,817,007 | 283,209 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $43,891,778 | 296,526 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $50,585,335 | 308,109 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $43,898,498 | 316,454 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||